Skip to main content

Find Drugs & Conditions

Drugs.com is the most popular, comprehensive and up-to-date source of drug information online. Providing free, peer-reviewed, accurate and independent data on more than 24,000 prescription drugs, over-the-counter medicines & natural products.

FDA Approves Penpulimab-kcqx for the Treatment of Advanced Nasopharyngeal Carcinoma

Akeso, Inc. (9926.HK) ("Akeso" or the "Company") is excited to announce that the U.S. Food and Drug Administration (FDA) has approved its differentiated...

Head Injuries Are a Growing Risk for Anesthesiologists, Experts Warn

SUNDAY, April 27, 2025 — One moment, Dr. Cornelius Sullivan was standing over a patient during surgery. The next, he woke up in an ambulance on the...

Where Have All The Insects Gone — And Why?

SATURDAY, April 26, 2025 — From beetles to moths, leafhoppers and butterflies, the world's insects are vanishing at a breakneck pace. Since 2017,...

HHS Announces Plans to Pay Moderna $176 Million for mRNA Flu Vaccine

On Tuesday, the U.S. Department of Health and Human Services announced that the government will invest $176 million in Moderna to expedite the creation...

Moderately Preterm Birth Tied to Long-Term Cognitive Problems

Moderately preterm birth is associated with cognitive problems at ages 9 to 10 years, according to a study published online April 14 in JAMA Network Open. Samson...

DDW: Systematic Program Increases Likelihood of Up-to-Date Colorectal Cancer Screening

A systematic program of monitoring colorectal cancer (CRC) screening status increases up-to-date screening status, according to a study presented at the...

USPSTF Recommends Counseling to Prevent Perinatal Depression

The U.S. Preventive Services Task Force (USPSTF) recommends counseling for women at increased risk for perinatal depression (PND). This recommendation...

Survey Reveals Women May Be Experiencing Perimenopause in Their 40s

Six in 10 women believe they will hit menopause in their 40s, according to survey results released April 8 by The Ohio State University Wexner Medical...

Novavax COVID Vaccine Moves Closer to Full FDA Approval

FRIDAY, April 25, 2025 — Novavax’s COVID-19 vaccine could soon receive full approval from the U.S. Food and Drug Administration (FDA), the...

These Three Bad Habits Can Harm Your Health As Young As Your Mid-30s

Bad habits like smoking, heavy drinking and skipping exercise can start to impact a person’s health as early as their mid-30s, a new study says. In...

Bristol Myers Squibb Announces Topline Results from Phase 3 ARISE Trial Evaluating Cobenfy (xanomeline and trospium chloride) as an Adjunctive Treatment to Atypical Antipsychotics in Adults with Schizophrenia

(BUSINESS WIRE) Apr 22, 2025 -- Bristol Myers Squibb (NYSE: BMY) today announced topline results from the Phase 3 ARISE trial evaluating the efficacy...

FDA Alerts Health Care Providers, Compounders and Consumers of Potential Risks Associated with Compounded Topical Finasteride Products

FDA has become aware of reports of adverse events involving compounded topical finasteride products potentially putting consumers at risk. The agency is...

Read more news...

Recently Added

Recently added consumer and prescribing information: Miudella, Opdivo Qvantig, Alyftrek, Crenessity, Ensacove, Steqeyma, Yesintek, Revuforj, Danziten, Aucatzyl

For Consumers

For Professionals

For Researchers

Latest FDA New Drug Approvals

  • Penpulimab-kcqx is a programmed death receptor-1 (PD-1)-blocking antibody for use in the treatment of nasopharyngeal carcinoma.
  • Jobevne Jobevne (bevacizumab-nwgd) is a vascular endothelial growth factor inhibitor biosimilar to Avastin used for the treatment of colorectal...
  • Vanrafia Vanrafia (atrasentan) is an endothelin A receptor antagonist used for proteinuria reduction in primary immunoglobulin (IgA) nephropathy.

More FDA approvals

Drugs in Development (Not yet approved)

  • Yutrepia Yutrepia (treprostinil) is an inhaled dry powder formulation of treprostinil tentatively approved for the treatment of pulmonary arterial...

More drugs in development